How many years does the FDA require research records pertaining to cancer patients to be maintained?

How many years does the FDA require research records pertaining to cancer patients to be maintained?

• A. 20 years
• B. 30 years
• C. 15 years
• D. 5 years

Answer: (B)

Long-term record retention in cancer research is essential because cancer therapies can have effects that emerge many years after treatment. The FDA requires keeping research records for a period that allows these late outcomes to be tracked, reanalyzed, and audited. For cancer patient studies, this period is thirty years, providing a safety net to examine long-term survival, late toxicities, secondary malignancies, and the overall trajectory of participants. Shorter retention could mean losing critical information as decades pass, which could hinder safety monitoring and scientific understanding. Therefore, the mandated retention time for cancer patient research records is thirty years.

Long-term record retention in cancer research is essential because cancer therapies can have effects that emerge many years after treatment. The FDA requires keeping research records for a period that allows these late outcomes to be tracked, reanalyzed, and audited. For cancer patient studies, this period is thirty years, providing a safety net to examine long-term survival, late toxicities, secondary malignancies, and the overall trajectory of participants. Shorter retention could mean losing critical information as decades pass, which could hinder safety monitoring and scientific understanding. Therefore, the mandated retention time for cancer patient research records is thirty years.